APA (7th ed.) Citation

JY, K., YR, D., KU, P., MK, K., KH, L., SH, B., . . . HS, S. (2010). A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer. Cancer Chemotherapy & Pharmacology, 66(1), 31. https://doi.org/10.1007/s00280-009-1130-6

Chicago Style (17th ed.) Citation

JY, Kim, Do YR, Park KU, Kim MK, Lee KH, Bae SH, Ryoo HM, Baek JH, and Song HS. "A Multi-center Phase II Study of Docetaxel Plus Cisplatin as First-line Therapy in Patients with Metastatic Squamous Cell Esophageal Cancer." Cancer Chemotherapy & Pharmacology 66, no. 1 (2010): 31. https://doi.org/10.1007/s00280-009-1130-6.

MLA (9th ed.) Citation

JY, Kim, et al. "A Multi-center Phase II Study of Docetaxel Plus Cisplatin as First-line Therapy in Patients with Metastatic Squamous Cell Esophageal Cancer." Cancer Chemotherapy & Pharmacology, vol. 66, no. 1, 2010, p. 31, https://doi.org/10.1007/s00280-009-1130-6.